Treatment modality | Comments |
Medical therapies | |
Sucralfate enemas | 1 RCT,101 several case series |
Metronidazole | 1 RCT102 used for 4 weeks in combination with corticosteroids and mesalazine (these last two agents probably ineffective if used alone). Possibly contraindicated if patient has already developed chemotherapy-induced peripheral neuropathy |
Vitamin A (retinol palmitate) | 1 small RCT103 and no endoscopic assessment performed |
Sulfasalazine | Case series |
Thalidomide | Case report |
Short chain fatty acids | Inconclusive RCT115 |
Rebampide enema therapy | Case series (not available in the UK) |
Other therapies | |
Hyperbaric oxygen treatment | I RCT,42 several case series |
Endoscopic laser ablation | Multiple case series, different lasers used. |
Endoscopic argon plasma coagulation | Multiple case series, serious complication rate 7-26% |
Endoscopic formalin application | Multiple case series, outcomes poorly assessed |
Surgical application of formalin | Multiple case series, outcomes poorly assessed |
Other references.6 7 116
RCT, randomised controlled trial.